Four-week pegylated interferon a-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study | Zendy

Akihito Tsubota | Zendy; Kenichi Satoh | Zendy; Mashu Aizawa | Zendy; Seishi Takamatsu | Zendy; Yoshihisa Namiki | Zendy; Toshifumi Ohkusa | Zendy; Kiyotaka Fujise | Zendy; Hisao Tajiri | Zendy

Open Access

Four-week pegylated interferon a-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study

Author(s) -

Akihito Tsubota,

Kenichi Satoh,

Mashu Aizawa,

Seishi Takamatsu,

Yoshihisa Namiki,

Toshifumi Ohkusa,

Kiyotaka Fujise,

Hisao Tajiri

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.7220

Subject(s) - medicine , pegylated interferon , gastroenterology , alpha interferon , viral load , interferon , interferon alfa , chronic hepatitis , peg ratio , immunology , ribavirin , virus , finance , economics

To assess the efficacy and advantages of 4-wk pegylated interferon alpha-2a (peg-IFN-alpha 2a) monotherapy for chronic hepatitis C patients with strong predictors of sustained virologic response (SVR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research